Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

Konermann, Silvana, Brigham, Mark D., Trevino, Alexandro E., Joung, Julia, Abudayyeh, Omar O., Barcena, Clea, Hsu, Patrick D., Habib, Naomi, Gootenberg, Jonathan S., Nishimasu, Hiroshi, Nureki, Osamu, Zhang, Feng·2015·Nature
DOI 10.1038/nature14136

Cited by (1,005)

Items 701–800 of 1,005

  1. Methods and applications of CRISPR/Cas system for genome editing in stem cells
    Guang Yang, Xingxu Huang · 2019 · Cell Regeneration
  2. Identification of X-chromosomal genes that drive sex differences in embryonic stem cells through a hierarchical CRISPR screening approach
    Oriana Genolet, Anna A. Monaco, Ilona Dunkel, Michael Boettcher, Edda G. Schulz · 2021 · Genome biology
  3. The protein arginine methyltransferase PRMT9 attenuates MAVS activation through arginine methylation
    Xuemei Bai, Chao Sui, Feng Liu, Tian Chen, Lei Zhang, Yi Zheng, Bingyu Liu, Chengjiang Gao · 2022 · Nature Communications
  4. Integrating machine learning and genome editing for crop improvement
    Long Chen, Guanqing Liu, Tao Zhang · 2024 · aBIOTECH
  5. Targeting specific DNA G-quadruplexes with CRISPR-guided G-quadruplex-binding proteins and ligands
    Geng Qin, Zhenqi Liu, Jie Yang, Xiaofeng Liao, Chuanqi Zhao, Jinsong Ren, Xiaogang Qu · 2024 · Nature Cell Biology
  6. Role of Angiomotin‐like 2 mono‐ubiquitination on YAP inhibition
    Miju Kim, Minchul Kim, Seong‐Jun Park, Cheolju Lee, Dae‐Sik Lim · 2015 · EMBO Reports
  7. A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes
    Feixiong Cheng, Junfei Zhao, Michaela Fooksa, Zhongming Zhao · 2016 · Journal of the American Medical Informatics Association
  8. An inducible CRISPR-ON system for controllable gene activation in human pluripotent stem cells
    Jianying Guo, Dacheng Ma, Rujin Huang, Jia Ming, Min Ye, Kehkooi Kee, Zhen Xie, Jie Na · 2017 · Protein & Cell
  9. Automated Design of Diverse Stand-Alone Riboswitches
    Michelle J. Wu, Johan O. L. Andreasson, Wipapat Kladwang, William James Greenleaf, Rhiju Das · 2019 · ACS Synthetic Biology
  10. Repurposing type I–F CRISPR–Cas system as a transcriptional activation tool in human cells
    Yuxi Chen, Jiaqi Liu, Shengyao Zhi, Qi Zheng, Wenbin Ma, Junjiu Huang, Yizhi Liu, Dan Liu, Puping Liang, Zhou Songyang · 2020 · Nature Communications
  11. Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
    Xingwu Zhou, Moyuan Qu, Peyton J. Tebon, Xing Jiang, Canran Wang, Yumeng Xue, Jixiang Zhu, Shiming Zhang, Rahmi Öklü, Shiladitya Sengupta et al. · 2020 · Advanced Science
  12. Synergistic Upregulation of Target Genes by TET1 and VP64 in the dCas9–SunTag Platform
    Sumiyo Morita, Takuro Horii, Mika Kimura, Izuho Hatada · 2020 · International Journal of Molecular Sciences
  13. Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer
    Jianhuang Lin, Heng Liu, Takeshi Fukumoto, Joseph A. Zundell, Qingqing Yan, Chih-Hang Anthony Tang, Shuai Wu, Wei Zhou, Dajiang Guo, Sergey V. Karakashev et al. · 2021 · Nature Communications
  14. A FLASH pipeline for arrayed CRISPR library construction and the gene function discovery of rice receptor-like kinases
    Kaiyuan Chen, Runnan Ke, Manman Du, Yuqing Yi, Yache Chen, Xiaochun Wang, Yao Lu, Hao Liu, Xin Hou, Lizhong Xiong et al. · 2021 · Molecular Plant
  15. Genetically-engineered mouse models of small cell lung cancer: the next generation
    Matthew G. Oser, David P MacPherson, Trudy G. Oliver, Julien Sage, Kwon-Sik Park · 2024 · Oncogene
  16. HBV integrations reshaping genomic structures promote hepatocellular carcinoma
    Zhaoyang Qian, Junbo Liang, Rong Huang, Wei Song, Jianming Ying, Xinyu Bi, Jianjun Zhao, Zhenyu Shi, Wenjie Liu, Jianmei Liu et al. · 2024 · Gut
  17. ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework
    Oleg N. Timofeev, Philippe Giron, Steffen Lawo, Martin Pichler, Amir Noeparast · 2024 · npj Precision Oncology
  18. Emerging trends in prime editing for precision genome editing
    Jaesuk Lee, Jiyeon Kweon, Yongsub Kim · 2025 · Experimental & Molecular Medicine
  19. CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
    Shuliang Chen, Xiao Yu, Deyin Guo · 2018 · Viruses
  20. A modular degron library for synthetic circuits in mammalian cells
    Hélène Chassin, Marius Müller, Marcel Tigges, Leo Scheller, Moritz Lang, Martin Fussenegger · 2019 · Nature Communications
  21. Localized delivery of CRISPR/dCas9 via layer-by-layer self-assembling peptide coating on nanofibers for neural tissue engineering
    Kunyu Zhang, Wai Hon Chooi, Shuang Liu, Jiah Shin Chin, Aoife Murray, Dean Nižetić, Du Cheng, Sing Yian Chew · 2020 · Biomaterials
  22. Elevated 4-hydroxynonenal induces hyperglycaemia via Aldh3a1 loss in zebrafish and associates with diabetes progression in humans
    Lou, Bowen, Boger, Mike, Bennewitz, Katrin, Sticht, Carsten, Kopf, Stefan, Morgenstern, Jakob, Fleming, Thomas, Hell, Rüdiger, Yuan, Zuyi, Nawroth, Peter Paul et al. · 2020 · Redox Biology
  23. Repurposing CRISPR System for Transcriptional Activation
    Meng Chen, Lei S. Qi · 2017 · Advances in experimental medicine and biology
  24. Cell Reprogramming With CRISPR/Cas9 Based Transcriptional Regulation Systems
    К. М. Шакирова, Viktoriia Y. Ovchinnikova, Erdem Bairovich Dashinimaev · 2020 · Frontiers in Bioengineering and Biotechnology
  25. Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing
    Wenhua Zhou, Haodong Cui, Liming Ying, Xue‐Feng Yu · 2018 · Angewandte Chemie
  26. CRISPR-RNAa: targeted activation of translation using dCas13 fusions to translation initiation factors
    Peter B. Otoupal, Brady F. Cress, Jennifer A. Doudna, Joseph S. Schoeniger · 2022 · Nucleic Acids Research
  27. Multicenter integrated analysis of noncoding CRISPRi screens
    David Yao, Josh Tycko, Jin Woo Oh, Lexi R. Bounds, Sager J. Gosai, Lazaros Lataniotis, Ava Mackay-Smith, Benjamin R. Doughty, Idan Gabdank, Henri Schmidt et al. · 2024 · Nature Methods
  28. Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations
    Chris C.‐S. Hsiung, Caroline M. Wilson, Nicholas A. Sambold, R. Dai, Q. Chen, Noam Teyssier, Sara Misiukiewicz, Abolfazl Arab, Thomas A. O’Loughlin, Joshua C. Cofsky et al. · 2024 · Nature Biotechnology
  29. Decoupling tRNA promoter and processing activities enables specific Pol-II Cas9 guide RNA expression
    David J. H. F. Knapp, Yale S. Michaels, Max Jamilly, Quentin R. V. Ferry, Hector Barbosa, Thomas A. Milne, Tudor A. Fulga · 2019 · Nature Communications
  30. Development and application of a CRISPR/Cas9 system for Bacillus licheniformis genome editing
    Cuixia Zhou, Huan Liu, Feiyan Yuan, Haonan Chai, Haikuan Wang, Fufeng Liu, Yu Li, Huitu Zhang, Fuping Lu · 2018 · International Journal of Biological Macromolecules
  31. Chromosome 19 microRNA cluster enhances cell reprogramming by inhibiting epithelial-to-mesenchymal transition
    Ezinne Francess Mong, Ying Yang, Kemal Marc Akat, John Canfield, Jeffrey VanWye, John H. Lockhart, John C.M. Tsibris, Frederick Schatz, Charles Joseph Lockwood, Thomas Tuschl et al. · 2020 · Scientific Reports
  32. Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation
    Dongdong Wang, Nayden G. Naydenov, Mikhail G. Dozmorov, Jennifer E. Koblinski, Andrei I. Ivanov · 2020 · Breast Cancer Research
  33. Moving from in vitro to in vivo CRISPR screens
    Maria Kuhn, António J. Santinha, Randall J. Platt · 2021 · Gene and Genome Editing
  34. Functional genomics bridges the gap between quantitative genetics and molecular biology
    Tuuli Lappalainen · 2015 · Genome Research
  35. High-resolution temporal transcriptome sequencing unravels ERF and WRKY as the master players in the regulatory networks underlying sesame responses to waterlogging and recovery
    Linhai Wang, Komivi Dossa, Jun You, Yanxin Zhang, Donghua Li, Rong Zhou, Jingyin Yu, Xin Wei, Xiaodong Zhu, Shiyang Jiang et al. · 2020 · Genomics
  36. Applications of CRISPR-Cas9 in Alzheimer’s Disease and Related Disorders
    Laura Maria De Plano, Giovanna Calabrese, Sabrina Conoci A, Salvatore P. P. Guglielmino, Salvatore Oddo, Antonella Caccamo · 2022 · International Journal of Molecular Sciences
  37. Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications
    Goldie V. Roth, Isabella R. Gengaro, Lei S. Qi · 2024 · Cell chemical biology
  38. A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway
    Alena Salašová, Chika Yokota, David Potěšil, Zbyněk Zdráhal, Vı́tězslav Bryja, Ernest Arenas · 2017 · Molecular Neurodegeneration
  39. MicroRNA-218 acts by repressing TNFR1-mediated activation of NF-κB, which is involved in MUC5AC hyper-production and inflammation in smoking-induced bronchiolitis of COPD
    Hui Xu, Qian Sun, Lu Lu, Fei Luo, Liang Zhou, Jianping Liu, Lei Cao, Qiushi Wang, Junchao Xue, Qianlei Yang et al. · 2017 · Toxicology Letters
  40. Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry
    Shirley Qiu, Anders Leung, Yuxia Bo, Robert Andrew Kozak, Sai Priya Anand, Corina Warkentin, Fabiola R.D. Salambanga, Jennifer Y. Cui, Gary Kobinger, Darwyn Kobasa et al. · 2017 · Virology
  41. Targeted Nucleotide Editing Technologies for Microbial Metabolic Engineering
    Takayuki Arazoe, Akihiko Kondo, Keiji Nishida · 2018 · Biotechnology Journal
  42. Systems Metabolic Engineering of Escherichia coli
    Kyeong Rok Choi, Jae Ho Shin, Jae Sung Cho, Dongsoo Yang, Sang Yup Lee · 2016 · EcoSal Plus
  43. Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects
    Mohammad Mijanur Rahman, Trygve O. Tollefsbol · 2020 · Methods
  44. CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy
    Lin Jiang, Jialiang Liang, Wei Chieh Huang, Jianyong Ma, Ki Ho Park, Zhichao Wu, Peng Chen, Hua Zhu C, Jianjie Ma, Wenfeng Cai et al. · 2021 · Molecular Therapy
  45. Functional disruption of cell wall invertase inhibitor by genome editing increases sugar content of tomato fruit without decrease fruit weight
    Kohei Kawaguchi, Rie Takei-Hoshi, Ikue Yoshikawa, Keiji Nishida, Makoto Kobayashi, Miyako Kusano, Yu Lu, Tohru Ariizumi, Hiroshi Ezura, Shungo Otagaki et al. · 2021 · Scientific Reports
  46. State-of-the-art CRISPR for in vivo and cell-based studies in Drosophila
    Jonathan D. Zirin, Justin A. Bosch, Raghuvir Viswanatha, Stephanie Elizabeth Mohr, Norbert Perrimon · 2021 · Trends in Genetics
  47. Epigenome editing: targeted manipulation of epigenetic modifications in plants
    Hosub Shin, Woo Lee Choi, Joo Young Lim, Jin Hoe Huh · 2022 · Genes & Genomics
  48. LINE-1 activation in the cerebellum drives ataxia
    Takehiro Takahashi, Milan Stoiljković, Eric Song, Xiao‐Bing Gao, Yuki Yasumoto, Eriko Kudo, Fernando Carvalho, Yong Kong, Annsea Park, Marya Shanabrough et al. · 2022 · Neuron
  49. Fluorogenic CRISPR for genomic DNA imaging
    Zhang, Zhongxuan, Rong, Xiaoxiao, Xie, Tianjin, Li, Zehao, Song, Haozhi, Zhen, Shujun, Wang, Haifeng, Wu, Jiahui, Jaffrey, Samie R., Li, Xing · 2024 · Nature Communications
  50. DNA methylation in epigenetic inheritance of metabolic diseases through the male germ line
    Illum, Louise Ruby Høj, Bak, Stine Thorhauge, Lund, Sten, Nielsen, Anders Lade · 2018 · Journal of Molecular Endocrinology
  51. A Review of CRISPR-Based Genome Editing: Survival, Evolution and Challenges
    Hafiz Ishfaq Ahmad, Muhammad Jamil Ahmad, Akhtar Rasool Asif, Muhammad Adnan, Muhammad Kashif Iqbal, Khalid Mehmood, Sayyed Aun Muhammad, Ali Akbar Bhuiyan, Abdelmotaleb Elokil, Xiaoyong Du et al. · 2018 · Current Issues in Molecular Biology
  52. CRISPR/Cas system: An emerging technology in stem cell research
    Maria Teresa Valenti, Michela Serena, Luca Dalle Carbonare, Donato Zipeto · 2019 · World Journal of Stem Cells
  53. Significance of Single-Nucleotide Variants in Long Intergenic Non-protein Coding RNAs
    Hecun Zou, Lanxiang Wu, Lihong Tan, Fei‐Fei Shang, Hong‐Hao Zhou · 2020 · Frontiers in Cell and Developmental Biology
  54. Identification of a quality-control factor that monitors failures during proteasome assembly
    Zavodszky, Eszter, Peak-Chew, Sew-Yeu, Juszkiewicz, Szymon, Narvaez, Ana J., Hegde, Ramanujan S. · 2021 · Science
  55. Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma
    Zhicheng Zhou, Mei-Ju May Chen, Yikai Luo, Kamalika Mojumdar, Xin Peng, Hu Chen, Shweta V. Kumar, Rehan Akbani, Yiling Lu, Han Liang · 2022 · Cancer Cell
  56. A CRISPR activation screen identifies FBXO22 supporting targeted protein degradation
    Ananya A. Basu, Chenlu Zhang, Isabella A. Riha, Assa Magassa, Miguel A. Lorenzo Campos, Alana G. Caldwell, Felicia Ko, Xiaoyu Zhang · 2024 · Nature Chemical Biology
  57. In vivo epigenome editing and transcriptional modulation using CRISPR technology
    Cia‐Hin Lau, Yousin Suh · 2018 · Transgenic Research
  58. CRISPR–Cas9 in genome editing: Its function and medical applications
    Saedeh Khadempar, Shokoufeh Familghadakchi, Roozbeh Akbari Motlagh, Najma Farahani, Maryam Dashtiahangar, Hamzeh Rezaei, Seyed Mohammad Gheibi Hayat · 2018 · Journal of Cellular Physiology
  59. CRISPR-SURF: discovering regulatory elements by deconvolution of CRISPR tiling screen data
    Jonathan Y. Hsu, Charles P. Fulco, Mitchel A. Cole, Matthew C. Canver, Danilo Pellin, Falak Sher, Rick Farouni, Kendell Clement, Jimmy A. Guo, Luca Biasco et al. · 2018 · Nature Methods
  60. Impact of CRISPR interference on strain development in biotechnology
    Kerstin Schultenkämper, Luciana Fernandes Brito, Volker F. Wendisch · 2020 · Biotechnology and Applied Biochemistry
  61. CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases
    Ansar Karimian, Negar Gorjizadeh, Forough Alemi, Zatollah Asemi, Khalil Azizian, Jafar Soleimanpour, Faezeh Malakouti, Niloufar Targhazeh, Maryam Majidinia, Bahman Yousefi · 2020 · Life Sciences
  62. Simultaneous quantification of mRNA and protein in single cells reveals post-transcriptional effects of genetic variation
    Christian Brion, Sheila Lutz, Frank Wolfgang Albert · 2020 · eLife
  63. Epigenetic basis and targeting of cancer metastasis
    Rakesh Banerjee, Jim Smith, Michael Roger Eccles, Robert J. Weeks, Aniruddha Chatterjee · 2021 · Trends in cancer
  64. Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing
    Jia Q. Lu, Chen Zhao, Yingze Zhao, Jingfang Zhang, Yue Zhang, Li Chen, Qiyuan Han, Ying Yue, Shuai Peng, Runna Ai et al. · 2017 · Nucleic Acids Research
  65. CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection
    Lijuan Yin, Siqi Hu, Shan Mei, Hong Sun, Fengwen Xu, Jian Li, Weijun Zhu, Xiaoman Liu, Fei Zhao, Di Zhang et al. · 2018 · Human Gene Therapy
  66. Real‐time observation of flexible domain movements in CRISPR–Cas9
    Saki Osuka, Kazushi Isomura, Shohei Kajimoto, Tomotaka Komori, Hiroshi Nishimasu, Tomohiro Shima, Osamu Nureki, Sotaro Uemura · 2018 · The EMBO Journal
  67. CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
    Stella Baliou, Maria Adamaki, Anthony M. Kyriakopoulos, Demetrios A. Spandidos, Mihalis I. Panayiotidis, Ioannis Christodoulou, Vassilis C. Zoumpourlis · 2018 · International Journal of Oncology
  68. C9-ALS/FTD-linked proline–arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation
    Hiroaki Suzuki, Yoshio Shibagaki, Seisuke Hattori, Masaaki Matsuoka · 2019 · Cell Death and Disease
  69. On-chip multiplexed single-cell patterning and controllable intracellular delivery
    Zaizai Dong, Yanli Jiao, Bingteng Xie, Yongcun Hao, Pan Wang, Yuanyuan Liu, Junfeng Shi, Chandani Chitrakar, Stephen M. Black, Yu-Chieh Wang et al. · 2020 · Microsystems & Nanoengineering
  70. Modeling the complex genetic architectures of brain disease
    Michael B. Fernando, Tim Ahfeldt, Kristen Brennand · 2020 · Nature Genetics
  71. Portable bacterial CRISPR transcriptional activation enables metabolic engineering in Pseudomonas putida
    Cholpisit Kiattisewee, Chen Dong, Jason T. Fontana, Widianti Sugianto, Pamela Peralta‐Yahya, James M. Carothers, Jesse G. Zalatan · 2021 · Metabolic Engineering
  72. Blackjack mutations improve the on-target activities of increased fidelity variants of SpCas9 with 5′ G-extended sgRNAs
    Kulcsár, Péter István, Tálas, András, Tóth, Eszter, Nyeste, Antal, Ligeti, Zoltán, Welker, Zsombor, Welker, Ervin · 2020 · Nature Communications
  73. HIF1α-AS1 is a DNA:DNA:RNA triplex-forming lncRNA interacting with the HUSH complex
    Matthias S. Leisegang, Jasleen Kaur Bains, Sandra Seredinski, James A. Oo, Nina M. Krause, Chao‐Chung Kuo, Stefan Günther, Nevcin Sentürk Cetin, Timothy Warwick, Can Cao et al. · 2022 · Nature Communications
  74. A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibility
    Junfan Guo, Wenxia Yu, Min Li, Hongyu Chen, Jie Liu, Xiaowen Xue, Jianxiang Lin, Shisheng Huang, Wenjie Shu, Xingxu Huang et al. · 2022 · Molecular Cell
  75. Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine
    Ruixuan Zheng, Lexiang Zhang, Rokshana Parvin, Lihuang Su, Junjie Chi, Keqing Shi, Fangfu Ye, Xiaoying Huang · 2023 · Advanced Science
  76. Multiplex, single-cell CRISPRa screening for cell type specific regulatory elements
    Florence M. Chardon, Troy A. McDiarmid, Nicholas F. Page, Riza M. Daza, Beth Martin, Silvia Domcke, Samuel G. Regalado, Jean‐Benoît Lalanne, Diego Calderon, Xiaoyi Li et al. · 2024 · Nature Communications
  77. Regulation of PCGEM1 by p54/nrb in prostate cancer
    Tsui-Ting Ho, Jianguo Huang, Nanjiang Zhou, Ziqiang Zhang, Pratirodh Koirala, Xinchun Zhou, Fangting Wu, Xianfeng Ding, Yin‐Yuan Mo · 2016 · Scientific Reports
  78. Epigenetic editing: How cutting-edge targeted epigenetic modification might provide novel avenues for autoimmune disease therapy
    Matlock Arizona Jeffries · 2018 · Clinical Immunology
  79. Challenges and opportunities with CRISPR activation in bacteria for data-driven metabolic engineering
    Jason T. Fontana, David Sparkman-Yager, Jesse G. Zalatan, James M. Carothers · 2020 · Current Opinion in Biotechnology
  80. Multiplex and optimization of dCas9‐TV‐mediated gene activation in plants
    Xiangyu Xiong, Jieping Liang, Zhenxiang Li, Ben‐Qiang Gong, Jianfeng Li · 2020 · Journal of Integrative Plant Biology
  81. Shape of promoter antisense RNAs regulates ligand-induced transcription activation
    Fan Yang, Bogdan Tanasă, Rudi Micheletti, Kenneth A. Ohgi, Aneel K. Aggarwal, Michael G. Rosenfeld · 2021 · Nature
  82. MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression in vivo
    Xin Zhang, Sihan Lv, Zhenhuan Luo, Yongfei Hu, Xin Peng, Jie Lv, Shanshan Zhao, Jianqi Feng, Guanjie Huang, Qin-Li Wan et al. · 2021 · Nucleic Acids Research
  83. Maybe you can turn me on: CRISPRa-based strategies for therapeutic applications
    Elvir Bećirović · 2022 · Cellular and Molecular Life Sciences
  84. GB_SynP: A Modular dCas9-Regulated Synthetic Promoter Collection for Fine-Tuned Recombinant Gene Expression in Plants
    Elena Moreno Giménez, Sara Selma, Camilo Calvache, Diego Orzáez · 2022 · ACS Synthetic Biology
  85. The lncRNA LUCAT1 is elevated in inflammatory disease and restrains inflammation by regulating the splicing and stability of NR4A2
    Tim Vierbuchen, Shiuli Agarwal, John L. Johnson, Liraz Shmuel-Galia, Xuqiu Lei, Karina Stein, David P. Olagnier, Karoline I. Gaede, Christian Herzmann, Christian Kanstrup Holm et al. · 2022 · Proceedings of the National Academy of Sciences
  86. STAT1 is required to establish but not maintain interferon‐γ‐induced transcriptional memory
    Sahar Tehrani, Paweł Mikulski, Izma Abdul‐Zani, João F. Mata, Wojciech Siwek, Lars E.T. Jansen · 2023 · The EMBO Journal
  87. Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional control
    Barun Mahata, Alan Cabrera, Daniel A. Brenner, Rosa Selenia Guerra-Resendez, Jing Li, Jacob Goell, Kaiyuan Wang, Yannie Guo, Mario Escobar, Abinand Krishna Parthasarathy et al. · 2023 · Nature Methods
  88. CRISPR activation screens: navigating technologies and applications
    Teleri Clark, Matthew A. Waller, Lipin Loo, Cesar L. Moreno, Christopher E. Denes, G. Gregory Neely · 2024 · Trends in biotechnology
  89. Programmable RNA targeting with CRISPR-Cas13
    Peiguo Shi, Xuebing Wu · 2024 · RNA Biology
  90. Electroporation Knows No Boundaries: The Use of Electrostimulation for siRNA Delivery in Cells and Tissues
    Christin Luft, Robin Ketteler · 2015 · SLAS DISCOVERY
  91. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease
    Sandy S. C. Hung, Tristan McCaughey, Olivia G. Swann, Alice Pébay, Alex William Hewitt · 2016 · Progress in Retinal and Eye Research
  92. The Past, Present, and Future of Genetic Manipulation in Toxoplasma gondii
    Jin‐Lei Wang, Si‐Yang Huang, Michael S. Behnke, Kai Chen, Bang Shen, Xing‐Quan Zhu · 2016 · Trends in Parasitology
  93. Optimised metrics for CRISPR-KO screens with second-generation gRNA libraries
    Swee Hoe Ong, Yilong Li, Hiroko Koike-Yusa, Kosuke Yusa · 2017 · Scientific Reports
  94. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery
    Gulzar Ahmad, Mansoor M. Amiji · 2018 · Drug Discovery Today
  95. CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering
    Bilal Ahmad Lone, Shibendra Kumar Lal Karna, Faiz Ahmad, Nerina Shahi, Yuba Raj Pokharel · 2018 · Genetics Research International
  96. Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer
    Panpan Zhang, Bin Kang, Guoyun Xie, Shaolei Li, Ying Gu, Yue Shen, Xin Zhao, Yuanyuan Ma, Fuqiang Li, Jiahui Si et al. · 2018 · Cancer Letters
  97. Osmosensing, osmosignalling and inflammation: how intervertebral disc cells respond to altered osmolarity
    Aleksandra Sadowska, Takuya Kameda, O Krupkova, Karin Wuertz‐Kozak · 2018 · European Cells and Materials
  98. Genome editing in wheat microspores and haploid embryos mediated by delivery of ZFN proteins and cell‐penetrating peptide complexes
    Andriy Bilichak, Lakshmi Sastry, Shreedharan Sriram, Matthew A. Simpson, Pon Samuel, Steve R. Webb, Fengying Jiang, François Eudes · 2019 · Plant Biotechnology Journal
  99. Fine-tuning gene expression for improved biosynthesis of natural products: From transcriptional to post-translational regulation
    Chenyi Li, Tian Jiang, Michelle Li, Yusong Zou, Yajun Yan · 2021 · Biotechnology Advances
  100. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence
    Kesavan Babu, Venkatesan Kathiresan, Pratibha Kumari, Sydney N. Newsom, Hari Priya Parameshwaran, Xiongping Chen, Jin Liu, Peter Zhifeng Qin, Rakhi Rajan · 2021 · Biochemistry